Home » Topics » Regulatory

Regulatory
RSS

Novo Nordisk's insulin degludec obtains first approval

Oct. 2, 2012

Dacogen gains approval in the E.U. for acute myeloid leukemia

Oct. 2, 2012

Suini approved in Japan for type 2 diabetes

Oct. 2, 2012

Plavix gets Japanese approval for additional indication

Oct. 2, 2012

FDA expands approval of Venofer to pediatric patients

Oct. 1, 2012

Dainippon Sumitomo Pharma obtains approval for Aimix combination tablets

Oct. 1, 2012

Seebri Breezhaler approved for COPD maintenance treatment in Japan

Oct. 1, 2012

FDA approves Bayer's Stivarga for treatment of metastatic colorectal cancer

Sep. 28, 2012

Regeneron's Eylea receives second U.S. approval

Sep. 27, 2012

FDA approves denosumab in new indication

Sep. 25, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...